SC - 1168 | Resistance to Targeted Therapies in Breast Cancer

in , , , , / with No comments /

Resistance to Targeted Therapies in Breast Cancer by by Jenifer R. Prosperi (Editor)

We present an in-depth description of resistance to targeted therapies in breast cancer. Targeted therapies discussed here include those used to treat ER+ or Her2+ breast cancers (i.e., Tamoxifen or trastuzumab) or those targeting signaling pathways aberrantly activated in triple negative breast cancer (i.e., EGFR and Wnt signaling).

We have also provided an overview of standard of care as an introduction into the importance of targeted therapy. It is our hope that this volume gives an insight into the landscape of breast cancer treatment, the challenges of targeted therapy, and a glimpse into the future of breast cancer therapy.

2017 | ISBN 978-3-319-70141-7 | ISBN 978-3-319-70142-4 | ID: SC - 1168

Napomena:
- clanovima nase biblioteke omogucen je pristup resursima Svetske elektronske biblioteke (World electronic library - WELIB), na linku WELIBRS, gde se mogu pronaci knjige na srpskom jeziku. Napominjemo da mi samo ostvarujemo saradnju sa ovom bibliotekom, a nismo njen deo.

- u jednom postu se nalazi onoliko knjiga od istog autora koliko smo ih dobili u tom trenutku - ako zelite da vidite kompletan spisak svih postavljenih knjiga istog autora na celom blogu - mozete ih pronaci putem stranice sa spiskom autora ili putem taga sa imenom autora ispod naslova odgovarajuceg posta.


IDENTIFIKACIONI (ID) BROJEVI:

SC:
1-100__101-200__201-300

301-400__401-500__501-600

601-700__701-800__801-900


0 comments:

Post a Comment

Comment form message

Subscribe to: Post Comments (Atom)